# The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People

> **NCT04658433** · NA · COMPLETED · sponsor: **Applied Science Private University** · enrollment: 100 (actual)

## Conditions studied

- Cardiovascular Risk Factor
- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** 300 mg of omega3-FA

## Key facts

- **NCT ID:** NCT04658433
- **Lead sponsor:** Applied Science Private University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2021-12-20
- **Final completion:** 2022-02-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04658433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04658433, "The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04658433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*